To assess the biological effects of inhibiting the interaction between endogenous talin and GFP-DLC1, we tested the ability of each talin wild-type and 2E mutant pair to antagonize the activity of co-transfected GFP-DLC1 in the A549 human non-small cell lung cancer line. The gene discussed is DLC1; the disease is non-small cell lung carcinoma.